ROYCE & ASSOCIATES LP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$205,000
-47.3%
4,809
-46.4%
0.00%
-33.3%
Q2 2021$389,000
-11.2%
8,976
-16.3%
0.00%0.0%
Q1 2021$438,000
-30.9%
10,728
-23.4%
0.00%
-40.0%
Q4 2020$634,000
+28.6%
13,999
+0.6%
0.01%0.0%
Q3 2020$493,000
-6.5%
13,921
-0.4%
0.01%
-16.7%
Q2 2020$527,000
+31.8%
13,972
+1.0%
0.01%
+20.0%
Q1 2020$400,000
-48.7%
13,829
-8.0%
0.01%
-28.6%
Q4 2019$780,000
-5.3%
15,039
+0.2%
0.01%
-12.5%
Q3 2019$824,000
+79.1%
15,008
+32.4%
0.01%
+100.0%
Q2 2019$460,000
+110.0%
11,335
+56.9%
0.00%
+100.0%
Q1 2019$219,000
+995.0%
7,226
+1096.4%
0.00%
Q4 2018$20,000
-13.0%
604
+12.1%
0.00%
Q3 2018$23,000
+130.0%
539
+71.7%
0.00%
Q2 2018$10,000
+42.9%
314
+112.2%
0.00%
Q1 2018$7,000
-12.5%
148
-3.9%
0.00%
Q4 2017$8,0000.0%154
+16.7%
0.00%
Q3 2017$8,000
-99.6%
132
-99.7%
0.00%
-100.0%
Q1 2016$2,078,000
-8.1%
46,465
-21.6%
0.01%
-7.1%
Q4 2015$2,262,000
+3670.0%
59,265
+4458.8%
0.01%
Q2 2014$60,000
+13.2%
1,3000.0%0.00%
Q1 2014$53,000
-13.1%
1,300
-18.8%
0.00%
Q4 2013$61,000
+32.6%
1,600
-15.8%
0.00%
Q3 2013$46,000
+43.8%
1,9000.0%0.00%
Q2 2013$32,0001,9000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Trigran Investments, Inc. 954,799$23,975,0002.44%
CAPITAL MANAGEMENT CORP /VA 202,258$5,079,0001.09%
Riverwater Partners LLC 12,370$311,0000.51%
DIKER MANAGEMENT LLC 21,835$548,0000.44%
Ranger Investment Management 136,381$3,425,0000.22%
CHATHAM CAPITAL GROUP, INC. 23,757$597,0000.12%
Teton Advisors, Inc. 22,000$552,0000.10%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,412,259$35,462,0000.09%
Intercontinental Wealth Advisors, LLC 14,257$358,0000.08%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 385,528$9,681,0000.06%
View complete list of ANIKA THERAPEUTICS INC shareholders